Dr. Murrell studies the complex interactions between HIV and the immune system, particularly how the body develops effective antibodies that can neutralize various strains of the virus. This research includes exploring specific antibody lineages that evolve in response to HIV infections and identifying mechanisms that can boost antibody responses through innovative vaccine strategies. His work not only targets HIV but also investigates broader concepts in disease control, including the effects of chronic stress hormones on metabolism, which can impact patients with diabetes and other conditions.
Key findings
Discovered a new broadly neutralizing antibody, PC39-1, formed after exposure to two founder viruses, crucial for informing future HIV vaccine strategies.
Demonstrated that modified HIV antibody PG9_N100(F)Y can neutralize 93% of HIV strains, significantly improving treatment potentials for people living with HIV.
Identified a 10% mutation rate in an HIV-fighting antibody that achieved broad effectiveness, paving the way for developing vaccines that mimic this natural antibody evolution.
Frequently asked questions
Does Dr. Murrell study HIV?
Yes, Dr. Murrell studies HIV, focusing on how the immune system develops antibodies that can effectively combat the virus.
What treatments has Dr. Murrell researched for HIV?
He has researched methods to enhance the effectiveness of antibodies against HIV, leading to potential new treatments.
Is Dr. Murrell's work relevant to patients living with HIV?
Absolutely, his research aims to improve treatments and vaccine strategies that directly benefit patients living with HIV.
Publications in plain English
Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodies.
2023
PLoS pathogens
Joyce C, Murrell S, Murrell B, Omorodion O, Ver LS +25 more
Plain English This study looked at how certain HIV infections help the body develop powerful antibodies that can fight different strains of the virus. Researchers found that two specific viruses led to the creation of a new type of antibody, called PC39-1, which has unusual features like extra amino acids that help it recognize the virus better. This is important because it shows that being exposed to multiple virus variants early on can help the immune system produce more effective antibodies, which could inform future vaccine designs.
Who this helps: This helps patients at risk of HIV by improving vaccine strategies.
Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design.
2018
Cell reports
Rantalainen K, Berndsen ZT, Murrell S, Cao L, Omorodion O +9 more
Plain English This study looked at how HIV and the immune system interact over time, focusing on broadly neutralizing antibodies (bnAbs) that target the HIV envelope. Researchers found that as the virus and antibodies evolved together, certain changes in the antibodies allowed them to better recognize and fight the virus. This information is crucial because it can help in designing better vaccines that encourage stronger and more effective immune responses against HIV.
Who this helps: This benefits patients at risk of HIV and helps researchers and vaccine developers.
Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity.
2017
Nature communications
Pantophlet R, Trattnig N, Murrell S, Lu N, Chau D +3 more
Plain English This study looked at a new way to trigger the immune system to create antibodies that can fight HIV by using synthetic substances that mimic a type of sugar found on the virus. The researchers created these mimetics from a bacterial component, which helped stimulate strong immune responses in animals, producing antibodies similar to ones that can effectively neutralize HIV. This is important because it opens up a potential pathway for developing vaccines or treatments that could more effectively combat HIV.
Who this helps: This helps patients at risk for HIV and researchers developing vaccines.
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage.
2017
Immunity
Landais E, Murrell B, Briney B, Murrell S, Rantalainen K +22 more
Plain English This study examined how a specific type of antibody that fights HIV became effective during natural infection. Researchers found that this antibody developed from a unique set of mutations and changes, using a heavy chain that is one of the shortest known for its type, achieving broad effectiveness with minimal changes—just a 10% mutation rate and no major alterations in its structure. These findings are important because they can inform the design of a potential HIV vaccine that mimics this natural development process.
Who this helps: This benefits researchers and vaccine developers working on HIV prevention.
Murrell B, Weaver S, Smith MD, Wertheim JO, Murrell S +7 more
Plain English This study introduced a new tool called BUSTED that helps researchers find genes that have been positively selected for a specific advantage over time. The researchers tested BUSTED against other methods using computer simulations and real data and found it to be effective in identifying genes that show evidence of rapid changes in specific lineages. This discovery matters because understanding how genes evolve can improve our knowledge of diseases and traits in different species, which can lead to better treatments and interventions.
Who this helps: This helps researchers and medical professionals studying genetics and evolutionary biology.
Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth.
2015
The Journal of clinical investigation
Willis JR, Sapparapu G, Murrell S, Julien JP, Singh V +9 more
Plain English The researchers studied a specific HIV-targeting antibody called PG9 and created a modified version to make it work better against various strains of the virus. They found that their new version, called PG9_N100(F)Y, was more effective at neutralizing 93% of HIV strains, including those that PG9 couldn't combat before. This is important because more effective antibodies can improve treatment options for people living with HIV.
Who this helps: This benefits patients living with HIV by providing potentially more effective treatments.
The genomes of many yam species contain transcriptionally active endogenous geminiviral sequences that may be functionally expressed.
2015
Virus evolution
Filloux D, Murrell S, Koohapitagtam M, Golden M, Julian C +11 more
Plain English This study examined the genomes of certain yam species to find traces of ancient viruses known as geminiviruses that may still be active. Researchers discovered two new types of these viral sequences in yam plants that have been part of their DNA for over 1.4 million years. They found that some of these sequences are still producing proteins that function in the plants, indicating that they could play a role in plant biology today.
Who this helps: This helps researchers and plant biologists better understand ancient viral interactions and their potential effects on plant health.
Review of dengue virus and the development of a vaccine.
2011
Biotechnology advances
Murrell S, Wu SC, Butler M
Plain English Researchers studied the dengue virus, which poses a growing health risk to over 2 billion people worldwide, particularly in tropical areas where infection rates are increasing. Despite ongoing efforts for the past sixty years, an effective vaccine that protects against all four types of dengue remains unavailable. Developing a cost-effective vaccine is crucial to reducing the financial burden on healthcare systems and protecting vulnerable populations, especially children, who are most affected by the disease.
Who this helps: This helps patients, especially children in tropical and subtropical regions, and healthcare providers managing dengue cases.
Comparison of in vitro erosion potentials between beverages available in the United Kingdom and the United States.
2010
Journal of dentistry
Murrell S, Marshall TA, Moynihan PJ, Qian F, Wefel JS
Plain English The study compared the effects of various drinks sold in the UK and the US on tooth enamel. It found that UK drinks like apple juice, orange juice, Diet Coke, and Sprite caused more damage to tooth enamel, with lesion depths being greater—up to 0.2 mm deeper—than similar US beverages. This matters because it highlights how the acidity and composition of common drinks can impact dental health differently depending on where you live.
Who this helps: This helps patients and dentists understand the potential risks of certain beverages on dental health.
Prenatal diagnosis with use of fetal cells isolated from maternal blood: five-color fluorescent in situ hybridization analysis on flow-sorted cells for chromosomes X, Y, 13, 18, and 21.
1998
American journal of obstetrics and gynecology
Bischoff FZ, Lewis DE, Nguyen DD, Murrell S, Schober W +3 more
Plain English This study looked at a new way to diagnose chromosome abnormalities in unborn babies using cells from a pregnant woman's blood, instead of more invasive methods like amniocentesis. Researchers tested this method on samples from 40 pregnant women and found that they could accurately identify conditions like Down syndrome in two cases with female fetuses and detected male chromosomes in 31% of cases with male fetuses. This is important because it offers a safer, non-invasive option for early detection of serious birth defects.
Who this helps: Expecting parents and healthcare providers.
Rare event selection of fetal nucleated erythrocytes in maternal blood by flow cytometry.
1996
Cytometry
Lewis DE, Schober W, Murrell S, Nguyen D, Scott J +4 more
Plain English This study looked at ways to effectively isolate fetal red blood cells from a pregnant person's blood for genetic testing. Researchers tested different methods and found that using a specific selection technique (gamma globin expression) successfully identified fetal cells in nearly 87% of samples (13 out of 15 pregnancies). This is important because it shows a promising step towards safer, noninvasive prenatal genetic testing.
Who this helps: This benefits expectant parents and healthcare providers by offering better methods for fetal health assessment.
Detection of low-grade mosaicism in fetal cells isolated from maternal blood.
1995
Prenatal diagnosis
Bischoff FZ, Lewis DE, Simpson JL, Nguyen DD, Scott J +3 more
Plain English This study looked at detecting a type of genetic variation called mosaicism in fetal cells taken from a mother's blood. Researchers found that, in one case, a woman whose initial tests showed normal genetic results actually had some fetal cells with an abnormal number of chromosomes (47 instead of 46). Specifically, they discovered 4 out of 500 cells examined had this variation, which shows that detailed testing can reveal hidden genetic conditions.
Who this helps: This helps expectant parents and healthcare providers who want more accurate prenatal genetic information.
Prototype decision support system for a differential diagnosis of psychotic, mood, and organic mental disorders: Part II.
1994
Medical decision making : an international journal of the Society for Medical Decision Making
Plant RT, Murrell S, Moreno HR
Plain English This study introduces a new decision support system designed to help doctors differentiate between various mental health disorders, specifically psychotic, mood, and organic conditions. By using advanced technology, this system aims to improve diagnostic accuracy, building on previous methods by using a more efficient 'parallel-processing' approach. The findings could lead to faster and more precise diagnoses, which are crucial for effective treatment.
Who this helps: This benefits doctors and mental health professionals in diagnosing patients more accurately.
The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog.
1994
Metabolism: clinical and experimental
McGuinness OP, Murrell S, Moran C, Bracy D, Cherrington AD
Plain English Researchers studied how removing glucagon, a hormone that raises blood sugar levels, affects the body’s response during a stress hormone infusion in dogs. They found that stopping glucagon decreased its levels significantly and slowed down the liver's ability to produce glucose by 40%, even though blood sugar levels were high. This research is important because it helps us understand how glucagon interacts with other hormones during stress, which can have implications for managing conditions like diabetes.
Who this helps: Patients with diabetes and healthcare providers.
Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog.
1993
The American journal of physiology
McGuinness OP, Fugiwara T, Murrell S, Bracy D, Neal D +2 more
Plain English This study looked at how long-term stress from hormones affects how dogs process sugar in their bodies. Researchers found that after 70 hours of stress hormone infusion, glucose levels in the dogs' blood nearly doubled from around 110 mg/dl to about 204 mg/dl, and their ability to produce glucose increased significantly by 80%. This matters because it shows that chronic stress can greatly affect blood sugar management, which could have implications for understanding similar effects in other animals, including humans.
Who this helps: This helps patients, particularly those dealing with stress-related blood sugar issues.